Joe Randolph

Senior Director of Sales and Marketing at Chembio Diagnostics - Medford, NY, US

Joe Randolph's Colleagues at Chembio Diagnostics
Diana Gumaer

Senior Director, QA/QC

Contact Diana Gumaer

Robert Gannon

Director, Channel Strategy and Partnerships

Contact Robert Gannon

Juan Alicea

Senior Formulation Laboratory Technician

Contact Juan Alicea

Paul Angelico

Executive Vice President and Chief Operations Officer at Chembio Diagnostic Systems, Inc.

Contact Paul Angelico

View All Joe Randolph's Colleagues
Joe Randolph's Contact Details
HQ
631-924-1135
Location
Morganville, New Jersey, United States
Company
Chembio Diagnostics
Joe Randolph's Company Details
Chembio Diagnostics logo, Chembio Diagnostics contact details

Chembio Diagnostics

Medford, NY, US • 100 - 249 Employees
Medical Equipment

About Chembio Diagnostics:Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com.About the DPP Rapid Test Platform:Chembio's proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio's easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.Chembio's portfolio of DPP-based point-of-care tests with FDA regulatory approvals include the DPP HIV-Syphilis System (PMA approved), DPP HIV 1/2 Assay (PMA approved and CLIA waived), DPP Zika IgM System (510(k)), and DPP Ebola Antigen System (EUA). Additionally, DPP-based tests have received regulatory approvals from the World Health Organization, CE-Mark, Agência Nacional de Vigilância Sanitária (ANVISA), and other global organizations.

B2B Biotechnology Healthcare Medical Devices Medical Diagnostics Pharmaceuticals Medical Equipment Medical and Hospital Equipment Research Development Business Services
Details about Chembio Diagnostics
Frequently Asked Questions about Joe Randolph
Joe Randolph currently works for Chembio Diagnostics.
Joe Randolph's role at Chembio Diagnostics is Senior Director of Sales and Marketing.
Joe Randolph's email address is ***@chembio.com. To view Joe Randolph's full email address, please signup to ConnectPlex.
Joe Randolph works in the Medical Equipment industry.
Joe Randolph's colleagues at Chembio Diagnostics are Diana Gumaer, Louise Sigismondi, Moira Bilich, Robert Gannon, Joseph Sagginario, Juan Alicea, Paul Angelico and others.
Joe Randolph's phone number is 631-924-1135
See more information about Joe Randolph